ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
Ciusss de L'Est de l'Île de Montréal
Ciusss de L'Est de l'Île de Montréal
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Hoosier Cancer Research Network
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Hoffmann-La Roche
Fred Hutchinson Cancer Center
Hangzhou Sumgen Biotech Co., Ltd.
Dana-Farber Cancer Institute
University of Alabama at Birmingham
Alliance for Clinical Trials in Oncology
Institute of Hematology & Blood Diseases Hospital, China
Mayo Clinic
Gracell Biotechnologies (Shanghai) Co., Ltd.
Fortvita Biologics (USA)Inc.
Dana-Farber Cancer Institute
ModernaTX, Inc.
AbbVie
BeOne Medicines
Hackensack Meridian Health
Hebei Senlang Biotechnology Inc., Ltd.
Hackensack Meridian Health
M.D. Anderson Cancer Center
Essen Biotech
AbbVie
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
AbbVie
Regeneron Pharmaceuticals
Celgene
Teva Branded Pharmaceutical Products R&D, Inc.
AstraZeneca
GlaxoSmithKline
Wake Forest University Health Sciences
Janssen Research & Development, LLC
University of Chicago
Karyopharm Therapeutics Inc
Genmab
CellCentric Ltd.
M.D. Anderson Cancer Center
Acerta Pharma BV
Dana-Farber Cancer Institute
Nanjing Leads Biolabs Co.,Ltd
Seoul National University Hospital
Incyte Corporation
Yale University
Mayo Clinic
Incyte Corporation
Incyte Corporation